Skip to main content

Annual monitoring for patients on persistent medications

CBE ID
0021
1.4 Project
Patient Safety Measures: Complications Endorsement Maintenance
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
Previous Endorsement Cycle
Fall 2012
Is Under Review
No
1.3 Measure Description

The percentage of members 18 years of age and older who received at least 180 treatment days of ambulatory medication therapy for a select therapeutic agent during the measurement year and at least one therapeutic monitoring event for the therapeutic agent in the measurement year. For each product line, report each of the four rates separately and as a total rate.

• Annual monitoring for members on angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARB)
• Annual monitoring for members on digoxin
• Annual monitoring for members on diuretics
• Annual monitoring for members on anticonvulsants
• Total rate (the sum of the four numerators divided by the sum of the four denominators)

    • 1.14 Numerator

      For annual monitoring for members on ACE inhibitors or ARBs, digoxin, and diuretics:

      The number of patients with at least one serum potassium and either a serum creatinine or a blood urea nitrogen therapeutic monitoring test in the measurement year.

      For annual monitoring for members on anticonvulsants:

      At least one drug serum concentration level monitoring test for the prescribed drug in the measurement year.

      Sum of the 4 numerators.

    • 1.15 Denominator

      Members on persistent medications—defined as members who received at least 180 treatment days of ambulatory medication in the measurement year.

    • Exclusions

      For Annual Monitoring for Members on Anticonvulsants:
      (optional) Members from each eligible population rate who had an inpatient (acute or nonacute) claim/encounter during the measurement year.

    • Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Patient Safety Measures: Complications Endorsement Maintenance Project
      Initial Endorsement
      Last Updated
      Removal Date
    • Steward
      National Committee for Quality Assurance
      Steward Organization POC Email
      [email protected]
      Steward Organization Copyright

      © 2011 by the National Committee for Quality Assurance
      1100 13th Street, NW, Suite 1000
      Washington, DC 20005